Bank of Ireland Financial Overview
Bank of Ireland
Slide 16: Total business income 10% higher
1. Business income including share of associates and JVs
2. Restated for impacts of IFRS 17 and transfer of Business Banking from Retail
Ireland into Corporate and Commercial
3. Acquisition of Davy completed 1 June 2022
Slide 17: Operating expenses' in line with c.€1.85bn guidance
1. Operating expenses excluding levies and regulatory charges of €170m
2. 2023 operating expenses reflect transfer of UK personal loans to non-core
from 1 Sept 2023; €4m in non-core items, €10m in reported operating
expenses of €1,857m
3. Restated for impact of IFRS 17
Slide 18: Non-core items of €85m
1. Portfolio divestments charge of €18 million includes income of €28m,
expenditure of €24m and impairment charges of €22m related to UK
personal loans
Slide 21: Higher impairment charge primarily due to additional
management adjustments
1. Underlying impairment charge of €403m reflects transfer of UK personal
loans to non-core from 1 Sept 2023; underlying impairment charge includes
€32m related to UK personal loans for period 1 Jan 2023 to 31 Aug 2023;
statutory impairment charge of €425m includes non-core impairment charge
of €22m
2. Excluding one-off gain of €47m related to recoveries received 2018-2021 in
respect of loans previously subject to ILA utilisation
3. Total stock of ILA for affordability assessment of retail portfolios of €33m
4. See slide 52 for macroeconomic assumptions used in IFRS 9 models
Slide 23: Significantly higher capital generation
1. Restated for impact of IFRS 17; reported FY22 RWA €47.5bn
2. Net organic capital generation primarily consists of attributable profit after
impairment and movements in regulatory deductions, and is calculated with
reference to RWAS at the start of the period
3. RWA movements from changes in loan book mix, asset quality, operational
risk RWA and movements in other RWAS
4. Subject to shareholder approval
Slide 25: Regulatory Ratios
1. Dec 2022 RWA and CET1 are restated in the FY23 report for the application of
IFRS 17 on 1 Jan 2023 (Dec 2022 RWA restated to €46.8bn; Regulatory CET1 to
15.6%.) CET1 impact of (30bps) is captured in the CET1 walk above
2. Net organic capital generation primarily consists of attributable profit after
impairment and movements in regulatory deductions, and is calculated with
reference to RWAS at the start of the period
3. RWA movements from changes in loan book mix, asset quality, operational
risk RWA and movements in other RWAS
Slide 28: Significant buffer to potential MDA restrictions
1. The Maximum Distributable Amount (MDA) is determined as a percentage of
attributable profits earned in the period to which the buffer breach and MDA
calculation pertains, and will vary depending on the extent of the breach
of the CBR which is measured in quartiles (bottom quartile - 0%, second
quartile - 20%, third quartile - 40% and top quartile - 60% of profits)
2. Includes c.7bps in respect of AT1 bucket shortfall
3. Future capital requirements reflect increase in ROI CCYB to 1.5% (effective
June 2024) and assumes no AT1 bucket shortfall. This is expected to increase
capital requirements by c.30bps
4. The MREL RWA requirement consists of a Single Resolution Board (SRB)
requirement of 23.75% and the Group's Combined Buffer Requirement (CBR)
of 5.16% on 1 January 2024 (comprising the Capital Conservation Buffer of
2.5%, and an OSII buffer of 1.5% and a CCyB of 1.16%)
39View entire presentation